Compugen Ltd. Logo

Compugen Ltd.

A clinical-stage company developing cancer immunotherapies using an AI platform.

CGEN | TA

Overview

Corporate Details

ISIN(s):
IL0010852080
LEI:
Country:
Israel
Address:
26 Harokmim St., Bldg D, 5885849 Holon

Description

Compugen Ltd. is a clinical-stage therapeutic discovery and development company specializing in cancer immunotherapy. A pioneer in its field, the company leverages a proprietary, broadly applicable, and predictive AI-powered computational discovery platform to identify novel drug targets. Its primary focus is on developing innovative, first-in-class therapeutics designed to modulate the tumor microenvironment and enhance anti-tumor immune responses. Compugen's mission is to advance its pipeline of drug candidates to address patient populations unresponsive to current immunotherapy treatments.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-17 15:05
6k-Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca …
English 158.1 KB
2025-12-17 15:05
6k-Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca …
English 36.4 KB
2025-12-17 15:00
Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for…
English 161.8 KB
2025-12-17 15:00
Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for…
English 36.5 KB
2025-11-10 15:00
Reports Third Quarter 2025 Results
English 516.5 KB
2025-11-10 15:00
Reports Third Quarter 2025 Results
English 36.4 KB
2025-11-04 15:00
Compugen to Participate in Stifel 2025 Healthcare Conference
English 149.5 KB
2025-11-04 15:00
Compugen to Participate in Stifel 2025 Healthcare Conference
English 36.4 KB
2025-10-27 14:00
Compugen to Release Third Quarter 2025 Results on Monday, November 10, 2025
English 130.8 KB
2025-10-27 14:00
Compugen to Release Third Quarter 2025 Results on Monday, November 10, 2025
English 36.4 KB
2025-10-14 16:00
Immediate Report
English 522.6 KB
2025-10-14 16:00
Immediate Report
English 36.6 KB
2025-10-13 16:00
Other Report or Announcement
English 159.5 KB
2025-10-13 16:00
Other Report or Announcement
English 36.5 KB
2025-10-06 16:00
Other Report or Announcement
English 159.9 KB

Automate Your Workflow. Get a real-time feed of all Compugen Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Compugen Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Compugen Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Circio Holding ASA Logo
Clinical-stage company developing circular RNA medicines and immunotherapies.
Norway
CRNA
CIZZLE BIOTECHNOLOGY HOLDINGS PLC Logo
A cancer diagnostics developer creating a blood test for early lung cancer detection.
United Kingdom
CIZ
CJ Bioscience Logo
Develops microbiome therapeutics for oncology and IBD using an AI-powered platform.
South Korea
311690
Climb Bio, Inc. Logo
Clinical-stage biotech developing therapies for immune-mediated diseases.
United States of America
CLYM
CODEXIS, INC. Logo
A protein engineering company developing enzymes for therapeutics and life sciences.
United States of America
CDXS
COGNITION THERAPEUTICS INC Logo
Clinical-stage company developing oral therapeutics for neurodegenerative disorders.
United States of America
CGTX
Combigene AB Logo
A gene therapy company focused on neurological disorders and chronic pain.
Sweden
COMBI
COMPUGEN LTD Logo
A clinical-stage company using AI to discover cancer immunotherapy drug targets.
United States of America
CGEN
CORESTEMCHEMON Inc. Logo
Develops stem cell therapies and provides non-clinical CRO preclinical services.
South Korea
166480
CRONEX.CO.,LTD Logo
A CRO supplying biological species and bio-tissue materials for medical research.
South Korea
215570

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.